ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,473.17
-0.25%
Dow Jones
39,134.76
0.77%
US Dollar vs MXN
18.33095
-0.13%
Brent Oil
84.905
-0.12%
Bitcoin
64,482.36
-0.52%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. IGM Biosciences Inc (IGMS)

  7. IGM Biosciences Inc (IGMS) Noticias

IGMS IGM Biosciences Inc

6.50
-0.74 (-10.22%)
20 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
IGM Biosciences Inc IGMS NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.74 -10.22% 6.50 18:23:35
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
7.15 6.455 7.41 6.51 7.24
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
20/6/202405:06EDGAR2Form SC TO-I - Tender offer statement by Issuer
18/6/202418:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202418:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202418:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202418:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202418:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202418:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202418:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202416:00EDGAR2Form SC TO-C - Written communication relating to an issuer..
14/6/202407:30EDGAR2Form 8-K - Current report
29/5/202406:00GLOBEIGM Biosciences to Present at the Jefferies Healthcare..
08/5/202415:10EDGAR2Form 8-K - Current report
08/5/202415:10GLOBEIGM Biosciences Announces First Quarter 2024 Financial..
08/5/202415:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202406:00GLOBEIGM Biosciences to Present at the 2024 RBCCM Global..
17/4/202407:30GLOBEIGM Biosciences Announces Refocusing of Sanofi Collaboration
10/4/202406:00GLOBEIGM Biosciences to Present at the Stifel 2024 Virtual..
07/3/202415:27EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/3/202415:10EDGAR2Form 8-K - Current report
07/3/202415:10GLOBEIGM Biosciences Announces Fourth Quarter and Full Year 2023..
05/3/202418:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202406:00GLOBEIGM Biosciences to Present at the Guggenheim Healthcare..
08/1/202408:00EDGAR2Form 8-K - Current report
03/1/202419:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202417:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202417:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202406:00GLOBEIGM Biosciences to Present at the 42nd Annual J.P. Morgan..
15/12/202318:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202318:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202318:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202316:36EDGAR2Form 144 - Report of proposed sale of securities
13/12/202316:33EDGAR2Form 144 - Report of proposed sale of securities
13/12/202316:30EDGAR2Form 144 - Report of proposed sale of securities
13/12/202316:27EDGAR2Form 144 - Report of proposed sale of securities
08/12/202315:05EDGAR2Form 8-K - Current report
05/12/202315:01GLOBEIGM Biosciences Announces Strategic Pipeline Prioritization..
01/12/202318:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202318:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202318:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202304:32PRNUSBulletin from Extraordinary General Meeting in Medivir AB..
29/11/202319:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202319:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202319:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
21/11/202301:48PRNUSMedivir to present at the Erik Penser Bank Company Event
13/11/202316:08EDGAR2Form S-3 - Registration statement under Securities Act of..
13/11/202315:10EDGAR2Form 8-K - Current report
13/11/202315:10GLOBEIGM Biosciences Announces Third Quarter 2023 Financial..
13/11/202315:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202306:00GLOBEIGM Biosciences to Present at Two Upcoming Investor..

Su Consulta Reciente

NASDAQ
IGMS
IGM Biosciences
LSE
SNIK
Wt Nickel 1x Sh
LSE
QK65
Morg.st.b.v 24
KOSPI
034830
Korea Real Estate Invest...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados